SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-21-005114
Filing Date
2021-03-01
Accepted
2021-03-01 16:42:49
Documents
1
Period of Report
2021-02-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2130
  Complete submission text file 0001493152-21-005114.txt   3824
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Gene Biotherapeutics, Inc. (Issuer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 6888 SOUTH IRVINGTON COURT AURORA CO 80016
Business Address
Jemapete Christopher J (Reporting) CIK: 0001741021 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33635 | Film No.: 21698616